Abstract:BackgroundTrifluridine/tiparacile is the second oral treatment approved for patients with mCRC who have received fluoropyrimidine, oxaliplin- and irinotecan-based chemotherapy, an anti-VEGF biologic therapy and, if RAS wild-type, an anti-EGFR.PurposeTo evaluate the efficacy and safety of patients treated with trifluridine plus tipiracil in a tertiary hospital in real-world data.Material and methodsRetrospective descriptive observational study was conducted. We included all patients from when the expanded acces… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.